Metatron, Inc. ($MRNJ) Receives First Sample Batch
Post# of 617763
DOVER, DE--(Marketwired - Jun 8, 2017) - Metatron (
As previously stated the Single Serve maker, which comes with a 16 ounce cup, is a great match for our Tea and Coffee blends. The maker brews in about 3 1/2 minutes and serves out at roughly 197 degrees from a starting cup temperature of near 72 degrees. This 197 degrees is almost ideal temperature for both of the new products.
"Our CBD infused Specialty coffee seems to have a sweet and tasty light cocoa taste that is faint, but not lost; a good mild blend with a slightly roasted finish and perhaps a nutty taste at the finish. It's hard to say what the CBD extract adds to the taste other than perhaps the nutty finish of the coffee. Our CBD infused Tea tasted excellent! I couldn't detect any cannabis aftertaste and as with both products, one has to consider an individual taste and amount of product used to fully express the tastes," said Mr. Riehl.
"Overall we at Metatron are pleased with the samples received and after meeting with other company officers next week a decision will be made as to initial order size and any changes that may or may not be made to the packaging design.
"Receiving these product samples moves Metatron one step closer to getting these products on the shelves for consumers and one step further in building a foundation of CBD derived products that will grow Metatron and increase our shareholder value," said Mr. Riehl.
Metatron's Apps: iTunes: https://itunes.apple.com/us/artist/i-mobilize...d325075390 Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc Facebook: http://www.facebook.com/metatroninc Twitter: http://twitter.com/metatroninc News: http://metatroninc.com/blog
Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company's operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's need for additional financing, which is not assured and which may result in dilution of shareholders, the company's status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement. Metatron does not grow, sell or distribute any substances that violate United States Law or the Controlled Substances Act.
Metatron, Inc. Joe Riehl 302-861-0431 ir@metatroninc.com
(0)
(0)